Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 687484, 7 pages
http://dx.doi.org/10.1155/2015/687484
Research Article

Semiannual Imaging Surveillance Is Associated with Better Survival in Patients with Non-B, Non-C Hepatocellular Carcinoma

First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi 409-3898, Japan

Received 1 June 2015; Accepted 9 July 2015

Academic Editor: Ekihiro Seki

Copyright © 2015 Kuniaki Shindo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. B. El-Serag and K. L. Rudolph, “Hepatocellular carcinoma: epidemiology and molecular carcinogenesis,” Gastroenterology, vol. 132, no. 7, pp. 2557–2576, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Chung, T. Ueda, and M. Kudo, “Changing trends in hepatitis C infection over the past 50 years in Japan,” Intervirology, vol. 53, no. 1, pp. 39–43, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Nouso, Y. Kobayashi, S. Nakamura et al., “Evolution of prognostic factors in hepatocellular carcinoma in Japan,” Alimentary Pharmacology and Therapeutics, vol. 31, no. 3, pp. 407–414, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Kumada, S. Nakano, I. Takeda et al., “Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma,” Hepatology, vol. 25, no. 1, pp. 87–92, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Miyagawa, S. Kawasaki, and M. Makuuchi, “Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: tumor multicentricity in cirrhotic liver with hepatitis C,” Hepatology, vol. 24, no. 2, pp. 307–310, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Takenaka, K. Yamamoto, A. Taketomi et al., “A comparison of the surgical results in patients with hepatitis B versus hepatitis C-related hepatocellular carcinoma,” Hepatology, vol. 22, no. 1, pp. 20–24, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Nagaoki, H. Hyogo, H. Aikata et al., “Recent trend of clinical features in patients with hepatocellular carcinoma,” Hepatology Research, vol. 42, no. 4, pp. 368–375, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Imura, M. Shimada, T. Utsunomiya et al., “Clinicopathological characteristics of patients with non-B non-C hepatocellular carcinoma: a special reference to metabolic syndrome,” Hepato-gastroenterology, vol. 61, no. 129, pp. 129–135, 2014. View at Google Scholar · View at Scopus
  9. B. Q. Starley, C. J. Calcagno, and S. A. Harrison, “Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection,” Hepatology, vol. 51, no. 5, pp. 1820–1832, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. E. G. Giannini, E. Marabotto, V. Savarino et al., “Hepatocellular carcinoma in patients with cryptogenic cirrhosis,” Clinical Gastroenterology and Hepatology, vol. 7, no. 5, pp. 580–585, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Nishikawa, A. Arimoto, T. Wakasa, R. Kita, T. Kimura, and Y. Osaki, “Comparison of clinical characteristics and survival after surgery in patients with non-B and non-C hepatocellular carcinoma and hepatitis virus-related hepatocellular carcinoma,” Journal of Cancer, vol. 4, no. 6, pp. 502–513, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Takuma, K. Nouso, Y. Makino et al., “Outcomes after curative treatment for cryptogenic cirrhosis-associated hepatocellular carcinoma satisfying the Milan criteria,” Journal of Gastroenterology and Hepatology, vol. 26, no. 9, pp. 1417–1424, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Bruix and M. Sherman, “Management of hepatocellular carcinoma,” Hepatology, vol. 42, no. 5, pp. 1208–1236, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Bruix and M. Sherman, “Management of hepatocellular carcinoma: an update,” Hepatology, vol. 53, no. 3, pp. 1020–1022, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Bruix, M. Sherman, J. M. Llovet et al., “Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver,” Journal of Hepatology, vol. 35, no. 3, pp. 421–430, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. U. Cillo, A. Vitale, F. Grigoletto et al., “Prospective validation of the Barcelona Clinic Liver Cancer staging system,” Journal of Hepatology, vol. 44, no. 4, pp. 723–731, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Jelic and G. C. Sotiropoulos, “Hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up,” Annals of Oncology, vol. 21, supplement 5, pp. v59–v64, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. J. A. Marrero, R. J. Fontana, A. Barrat et al., “Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort,” Hepatology, vol. 41, no. 4, pp. 707–716, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Omata, L. A. Lesmana, R. Tateishi et al., “Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma,” Hepatology International, vol. 4, no. 2, pp. 439–474, 2010. View at Publisher · View at Google Scholar
  20. L. Bolondi, S. Sofia, S. Siringo et al., “Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis,” Gut, vol. 48, no. 2, pp. 251–259, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. A. C. Y. Chan, R. T. P. Poon, K. K. C. Ng, C. M. Lo, S. T. Fan, and J. Wong, “Changing paradigm in the management of hepatocellular carcinoma improves the survival benefit of early detection by screening,” Annals of Surgery, vol. 247, no. 4, pp. 666–673, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. A. M. Di Bisceglie, “Issues in screening and surveillance for hepatocellular carcinoma,” Gastroenterology, vol. 127, no. 5, supplement 1, pp. S104–S107, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. W. R. Kim, G. J. Gores, J. T. Benson, T. M. Therneau, and L. J. Melton III, “Mortality and hospital utilization for hepatocellular carcinoma in the United States,” Gastroenterology, vol. 129, no. 2, pp. 486–493, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Pascual, J. Irurzun, P. Zapater et al., “Usefulness of surveillance programmes for early diagnosis of hepatocellular carcinoma in clinical practice,” Liver International, vol. 28, no. 5, pp. 682–689, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. European Association for the Study of the Liver and European Organisation for Research and Treatment of Cancer, “EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma,” Journal of Hepatology, vol. 56, no. 4, pp. 908–943, 2012. View at Publisher · View at Google Scholar
  26. K. H. Han and J. K. Kim, “Liver cancer in Korea,” Hepatology Research, vol. 37, supplement 2, pp. S106–S109, 2007. View at Google Scholar
  27. F. Trevisani, S. De Notariis, G. Rapaccini et al., “Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience),” American Journal of Gastroenterology, vol. 97, no. 3, pp. 734–744, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Vallet-Pichard, V. Mallet, B. Nalpas et al., “FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and FibroTest,” Hepatology, vol. 46, no. 1, pp. 32–36, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. B. K. Kim, J. Fung, M.-F. Yuen, and S. U. Kim, “Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives,” World Journal of Gastroenterology, vol. 19, no. 12, pp. 1890–1900, 2013. View at Publisher · View at Google Scholar · View at Scopus